Is homozygous deletion of the survival motor neuron 2 gene a prognostic factor in sporadic ALS?
These results indicate that, similar to SMA, the SMN2 gene can act as a prognostic factor and may therefore be a phenotypic modifier in sporadic ALS. Increasing the expression of the SMN2 gene may provide a strategy for treatment of motor neuron disease.
Christmas tree banding with finger pressure measurements can offer successful treatment for DASS.